Market Overview

Zoetis Soars On News Of Ackman Stake

Share:
Related ZTS
Watch These 8 Huge Call Purchases In Monday Trade
Wall Street's M&A Chatter From January 18

It was reported Tuesday that activist investor Bill Ackman has accumulated a "roughly $2 billion stake" in Zoetis Inc (NYSE: ZTS).

The stock spiked on the news, soaring nearly 10 percent.

According to the report, Ackman “could push the animal-health company to sell itself to a
 large drug maker like Valeant Pharmaceuticals International Inc.”

“Mr. Ackman's Pershing Square Capital Management LP has built the stake, which amounts to roughly 10 percent of Zoetis, with fellow hedge fund Sachem Head Capital Management LP,” according to sources familiar with the developments.

A Dow Jones report noted that a “spokesman for Florham Park, N.J.-based Zoetis, which has a market value of about $20 billion, said the company got a call from Mr. Ackman regarding
the investment, but declined to comment on it.”

Zoetis closed at $43.72, up 8.8 percent.

Posted-In: Dow Jones Pershing Square Sachem Head CapitalNews

 

Related Articles (ZTS)

View Comments and Join the Discussion!